peplexicon
Choose your depth

Context, anatomy, and key evidence

← Peptide library

SNAP-25 inhibitor peptide

Argireline

Published evidence · coverage incomplete
Anatomical contextAnatomy connections are not mapped yet.

No body region is highlighted until this profile has a supported anatomical connection. This does not mean the peptide has no biological effects.

Read published mechanism findings ↓

At a glance

What is it—and why does it matter?

An introduction is not yet available. The findings below address specific research questions, not a complete account of this peptide.

This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.

What is it?

A molecule, not a product name.

Identity

This statement identifies argireline as part of a multi-component self-assembled nanoparticle system; it does not describe argireline alone.

Sources[1]pubmedDES-mediated self-assembled polypeptides: Synergistic neuromuscular signaling inhibition for anti-aging.DAC-SAP integrates dipeptide diaminobutyryl benzamide diacetate (DDB), argireline (ARG), and μ-conotoxin (CTX) into a single nanostructure through hydrophobic interactions, hydrogen bonds, and electrostatically driven molecular self-assembly.
Source records
1
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    “DAC-SAP integrates dipeptide diaminobutyryl benzamide diacetate (DDB), argireline (ARG), and μ-conotoxin (CTX) into a single nanostructure through hydrophobic interactions, hydrogen bonds, and electrostatically driven molecular self-assembly.”

    DES-mediated self-assembled polypeptides: Synergistic neuromuscular signaling inhibition for anti-aging. · Abstract

    pubmed:42202650:8635f8dd3f21:8635f8dd3f21

How does it work?

Target, response, and disposition.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

What has been studied?

What the evidence says.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Risks and interactions

Risks, organized for scanning.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Products and regulatory status

Same ingredient. Different records.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Administration context

The practical clinical context.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Research status + gaps

What still needs better answers?

  • No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
  • 56 compiled claim(s) withheld by automated assurance: assurance_score_below_0.58 (38), assurance_score_below_0.72 (18), current_regulatory_source_required (11), extraction_ambiguity (16), high_risk_requires_regulatory_or_two_independent_sources (18), no_direct_support (56)

These are the limits of this profile, not an exhaustive list of scientific uncertainties.

References + discovery

Open the records yourself.

  1. DES-mediated self-assembled polypeptides: Synergistic neuromuscular signaling inhibition for anti-aging. ↗

    pubmed · published 2026-10-01 · retrieved 2026-08-25T22:43:25Z

Publication history and provenance

Version 4 · Automated assessment · 2026-08-25T22:43:25Z

da63074eec8bbfc63978bca657dc457fe480083c29157f010ee618c387c68308